Table 2.
Commonly over-expressed genes in both datasets
| Concurrent analysis* | ||
|---|---|---|
| Symbol | Name | Process/function |
| SCG5 | Secretogranin V (7B2 protein) | Transport/Enzyme inhibitor activity |
| PCSK1 | Proprotein convertase subtilisin/kexin type 1 | Energy reserve metabolic process/Endopeptidase activity |
| SCN3A | Sodium channel, voltage-gated, type III, alpha subunit | Ion transport/Voltage-gated ion channel activity |
| PNMA2 | Paraneoplastic Ma antigen 2 | Apoptotic process/Protein binding |
| NKX2-2 | NK2 homeobox 2 | Type B pancreatic cell development/Core promoter proximal region DNA binding |
| SCG2 | Secretogranin II | MAPK cascade/Cytokine activity |
| ST18 | Suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein) | Negative regulation of transcription from RNA polymerase II promoter/DNA binding |
| INSM1 | Insulinoma-associated 1 | Regulation of transcription, DNA-dependent/DNA binding |
| CPE | Carboxypeptidase E | Cardiac left ventricle morphogenesis/Carboxypeptidase activity |
| BEX1 | Brain expressed, X-linked 1 | Multicellular organismal development/RNA polymerase II activating transcription factor binding |
| APLP1 | Amyloid beta (A4) precursor-like protein 1 | MRNA polyadenylation/Protein binding |
| AKT3 | V-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | Mitochondrial genome maintenance/Nucleotide binding |
| CD59 | CD59 molecule, complement regulatory protein | Cell surface receptor signaling pathway/Protein binding |
*This manuscript.